Enquiry/Quote
No Image Available

Dalteparin Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 2500IU

Reference Brands:

Category: Respiratory Disorder

Injection is an anticoagulant medication containing the active constituent dalteparin. It prevents the formation of blood clots by thinning the blood. It is used in the treatment of a condition called venous thromboembolism, where blood clots develop in the lungs (pulmonary embolism) or the legs (deep vein thrombosis) after surgery, in bedridden patients, or in patients with certain types of cancer.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

πŸ“˜ Sourcing Guide

Product Description: Talk to your doctor if you have an active ulcer, bleeding disorders, liver failure, hemophilia, injury to an operation involving head, spine, eye or ears, septic endocarditis (infection in heart) and condition called heparin-induced thrombocytopenia (decrease in the number of platelets caused by heparin). Inform your doctor if you have uncontrolled blood pressure, and diabetes.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Related Products

Salmeterol Xinafoate

Strength:
25 Β΅g, 50 Β΅g

Form: Inhalation

Reference Brands: Serevent (USA/LATAM/EU)

View Details
Formoterol Fumarate

Strength:
12 Β΅g

Form: Inhalation

Reference Brands: Foradil (USA/LATAM), Oxis (India)

View Details
Ethionamide

Strength:
250 mg

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details
Olodaterol

Strength:
2.5 mcg

Form: Inhalation solution

Reference Brands: Striverdi Respimat (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.